Inventor
TWYMAN ROY E
US12 patents
⚠️ This page may combine multiple inventors who share the name “TWYMAN ROY E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORTHO MCNEIL PHARM INC
5 patentsUS6562867B2May 13, 2003
Carbamate compounds for use in preventing or treating bipolar disorder
ORTHO MCNEIL PHARM INC34 citations92
US7078436B2Jul 18, 2006
Carbamate compounds for use in preventing or treating anxiety disorders
ORTHO MCNEIL PHARM INC36 citations91
US6589985B2Jul 8, 2003
Carbamate compounds for use in preventing or treating movement disorders
ORTHO MCNEIL PHARM INC39 citations91
US6541513B2Apr 1, 2003
Carbamate compounds for use in preventing or treating psychotic disorders
ORTHO MCNEIL PHARM INC14 citations83
US6815464B2Nov 9, 2004
Carbamate compounds for use in the treatment of pain
ORTHO MCNEIL PHARM INC7 citations72
JANSSEN PHARMACEUTICA NV
4 patentsUS10537573B2Jan 21, 2020
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JANSSEN PHARMACEUTICA NV1 citations68
US12048696B2Jul 30, 2024
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JANSSEN PHARMACEUTICA NV0 citations57
US11369606B2Jun 28, 2022
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JANSSEN PHARMACEUTICA NV1 citations57
US11103506B2Aug 31, 2021
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
JANSSEN PHARMACEUTICA NV0 citations57